Casdin Capital’s Teladoc Health TDOC Stock Holding History

Casdin Capital’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300,000	Closed	-$2.39M	–	41
2025 Q1	$2.39M	Buy	+300,000	New	+$3.03M	0.2%	34

Other funds holding TDOC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

MRCP

Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return

Casdin Capital's TDOC Position: Q2 2025 in Review

Casdin Capital sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 300,000 shares — an estimated $2.39M sold.

Casdin Capital first reported a position in TDOC in Q1 2025 and held it in 1 quarter. The position peaked at $2.39M in Q1 2025. 358 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

Casdin Capital reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
Casdin Capital sold 300,000 Teladoc Health shares in Q2 2025, an estimated $2.39M.
Casdin Capital first reported a position in Teladoc Health in Q1 2025 and held it in 1 quarter.
Casdin Capital's Teladoc Health position peaked at $2.39M in Q1 2025.
358 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Casdin Capital's 13F filing for Q2 2025, filed 14 Aug 2025.